<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">33532785</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><JournalIssue CitedMedium="Internet"><PubDate><Year>2021</Year><Month>Jan</Month><Day>30</Day></PubDate></JournalIssue><Title>medRxiv : the preprint server for health sciences</Title><ISOAbbreviation>medRxiv</ISOAbbreviation></Journal><ArticleTitle>More than 50 Long-term effects of COVID-19: a systematic review and meta-analysis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2021.01.27.21250617</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1101/2021.01.27.21250617</ELocationID><Abstract><AbstractText>COVID-19, caused by SARS-CoV-2, can involve sequelae and other medical complications that last weeks to months after initial recovery, which has come to be called Long-COVID or COVID long-haulers. This systematic review and meta-analysis aims to identify studies assessing long-term effects of COVID-19 and estimates the prevalence of each symptom, sign, or laboratory parameter of patients at a post-COVID-19 stage. LitCOVID (PubMed and Medline) and Embase were searched by two independent researchers. All articles with original data for detecting long-term COVID-19 published before 1<sup>st</sup> of January 2021 and with a minimum of 100 patients were included. For effects reported in two or more studies, meta-analyses using a random-effects model were performed using the MetaXL software to estimate the pooled prevalence with 95% CI. Heterogeneity was assessed using <i>I</i><sup>2</sup> statistics. This systematic review followed Preferred Reporting Items for Systematic Reviewers and Meta-analysis (PRISMA) guidelines, although the study protocol was not registered. A total of 18,251 publications were identified, of which 15 met the inclusion criteria. The prevalence of 55 long-term effects was estimated, 21 meta-analyses were performed, and 47,910 patients were included. The follow-up time ranged from 14 to 110 days post-viral infection. The age of the study participants ranged between 17 and 87 years. It was estimated that 80% (95% CI 65-92) of the patients that were infected with SARS-CoV-2 developed one or more long-term symptoms. The five most common symptoms were fatigue (58%), headache (44%), attention disorder (27%), hair loss (25%), and dyspnea (24%). All meta-analyses showed medium (n=2) to high heterogeneity (n=13). In order to have a better understanding, future studies need to stratify by sex, age, previous comorbidities, severity of COVID-19 (ranging from asymptomatic to severe), and duration of each symptom. From the clinical perspective, multi-disciplinary teams are crucial to developing preventive measures, rehabilitation techniques, and clinical management strategies with whole-patient perspectives designed to address long COVID-19 care.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lopez-Leon</LastName><ForeName>Sandra</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-7504-3441</Identifier><AffiliationInfo><Affiliation>Drug Development, Novartis Pharmaceuticals, New Jersey, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wegman-Ostrosky</LastName><ForeName>Talia</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-3207-6697</Identifier><AffiliationInfo><Affiliation>Instituto Nacional de Cancerolog&#xed;a, Subdirecci&#xf3;n de Investigaci&#xf3;n b&#xe1;sica, Ciudad de M&#xe9;xico, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perelman</LastName><ForeName>Carol</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-0111-1154</Identifier><AffiliationInfo><Affiliation>National Autonomous University of Mexico, SOMEDICyT, RedMPC, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sepulveda</LastName><ForeName>Rosalinda</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-1146-9552</Identifier><AffiliationInfo><Affiliation>Harvard T.H. Chan School of Public Health Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rebolledo</LastName><ForeName>Paulina A</ForeName><Initials>PA</Initials><Identifier Source="ORCID">0000-0002-9808-063X</Identifier><AffiliationInfo><Affiliation>Divison of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cuapio</LastName><ForeName>Angelica</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-9451-1914</Identifier><AffiliationInfo><Affiliation>Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institute, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Villapol</LastName><ForeName>Sonia</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-6174-4113</Identifier><AffiliationInfo><Affiliation>Department of Neurosurgery, Center for Neuroregeneration, Houston Methodist Research Institute, Houston, Texas, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuroscience in Neurological Surgery, Weill Cornell Medical College, New York, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R21 NS106640</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D000076942">Preprint</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>01</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>medRxiv</MedlineTA><NlmUniqueID>101767986</NlmUniqueID></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="UpdateIn"><RefSource>Sci Rep. 2021 Aug 9;11(1):16144. doi: 10.1038/s41598-021-95565-8</RefSource><PMID Version="1">34373540</PMID></CommentsCorrections></CommentsCorrectionsList><CoiStatement>Conflict of interest statement SLL is an employee of Novartis Pharmaceutical Company; the statements presented in the paper do not necessarily represent the position of the company. The remaining authors have no competing interests to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>2</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>2</Month><Day>4</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>2</Month><Day>3</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>2</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33532785</ArticleId><ArticleId IdType="pmc">PMC7852236</ArticleId><ArticleId IdType="doi">10.1101/2021.01.27.21250617</ArticleId><ArticleId IdType="pii">2021.01.27.21250617</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hannah Ritchie EO-O, Diana Beltekian, Edouard Mathieu, Joe Hasell, Bobbie Macdonald, Charlie Giattino, and Max Roser. Coronavirus Pandemic (COVID-19). 2021.</Citation></Reference><Reference><Citation>Tenforde MW, Kim SS, Lindsell CJ, et al. Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network - United States, March-June 2020. MMWR Morb Mortal Wkly Rep 2020; 69(30): 993&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L, Dowds J, O&#x2019;Brien K, et al. Persistent Poor Health Post-COVID-19 Is Not Associated with Respiratory Complications or Initial Disease Severity. Ann Am Thorac Soc 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8456724</ArticleId><ArticleId IdType="pubmed">33413026</ArticleId></ArticleIdList></Reference><Reference><Citation>Gemelli Against C-P-ACSG. Post-COVID-19 global health strategies: the need for an interdisciplinary approach. Aging Clin Exp Res 2020; 32(8): 1613&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7287410</ArticleId><ArticleId IdType="pubmed">32529595</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T, Knight M, A&#x2019;Court C, Buxton M, Husain L. Management of post-acute covid-19 in primary care. BMJ 2020; 370: m3026.</Citation><ArticleIdList><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Q, Allot A, Lu Z. LitCovid: an open database of COVID-19 literature. Nucleic Acids Res 2021; 49(D1): D1534&#x2013;D40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7778958</ArticleId><ArticleId IdType="pubmed">33166392</ArticleId></ArticleIdList></Reference><Reference><Citation>Shamseer L, Moher D, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ 2015; 350: g7647.</Citation><ArticleIdList><ArticleId IdType="pubmed">25555855</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 2015; 4: 1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4320440</ArticleId><ArticleId IdType="pubmed">25554246</ArticleId></ArticleIdList></Reference><Reference><Citation>Barendregt JJ, Doi SA, Lee YY, Norman RE, Vos T. Meta-analysis of prevalence. J Epidemiol Community Health 2013; 67(11): 974&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">23963506</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong Q, Xu M, Li J, et al. Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. Clin Microbiol Infect 2021; 27(1): 89&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7510771</ArticleId><ArticleId IdType="pubmed">32979574</ArticleId></ArticleIdList></Reference><Reference><Citation>Goertz YMJ, Van Herck M, Delbressine JM, et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res 2020; 6(4).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7491255</ArticleId><ArticleId IdType="pubmed">33257910</ArticleId></ArticleIdList></Reference><Reference><Citation>Carfi A, Bernabei R, Landi F, Gemelli Against C-P-ACSG. Persistent Symptoms in Patients After Acute COVID-19. JAMA 2020; 324(6): 603&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Alwan NA. Track COVID-19 sickness, not just positive tests and deaths. Nature 2020; 584(7820): 170.</Citation><ArticleIdList><ArticleId IdType="pubmed">32782377</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L, Dyer AH, Jones K, et al. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS One 2020; 15(11): e0240784.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7652254</ArticleId><ArticleId IdType="pubmed">33166287</ArticleId></ArticleIdList></Reference><Reference><Citation>Neufeld KJ, Leoutsakos JS, Yan H, et al. Fatigue Symptoms During the First Year Following ARDS. Chest 2020; 158(3): 999&#x2013;1007.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7478232</ArticleId><ArticleId IdType="pubmed">32304774</ArticleId></ArticleIdList></Reference><Reference><Citation>Wostyn P. COVID-19 and chronic fatigue syndrome: Is the worst yet to come? Med Hypotheses 2021; 146: 110469.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7836544</ArticleId><ArticleId IdType="pubmed">33401106</ArticleId></ArticleIdList></Reference><Reference><Citation>Vink M, Vink-Niese A. Could Cognitive Behavioural Therapy Be an Effective Treatment for Long COVID and Post COVID-19 Fatigue Syndrome? Lessons from the Qure Study for Q-Fever Fatigue Syndrome. Healthcare (Basel) 2020; 8(4).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7764131</ArticleId><ArticleId IdType="pubmed">33322316</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamprecht B. [Is there a post-COVID syndrome?]. Pneumologe (Berl) 2020: 1&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7543035</ArticleId><ArticleId IdType="pubmed">33052198</ArticleId></ArticleIdList></Reference><Reference><Citation>Pallanti S, Grassi E, Makris N, Gasic GP, Hollander E. Neurocovid-19: A clinical neuroscience-based approach to reduce SARS-CoV-2 related mental health sequelae. J Psychiatr Res 2020; 130: 215&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7428715</ArticleId><ArticleId IdType="pubmed">32836010</ArticleId></ArticleIdList></Reference><Reference><Citation>Nath A. Long-Haul COVID. Neurology 2020; 95(13): 559&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">32788251</ArticleId></ArticleIdList></Reference><Reference><Citation>Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness. Mil Med 2015; 180(7): 721&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">26126237</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal A, Marshall T. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in the Era of the Human Microbiome: Persistent Pathogens Drive Chronic Symptoms by Interfering With Host Metabolism, Gene Expression, and Immunity. Front Pediatr 2018; 6: 373.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6288442</ArticleId><ArticleId IdType="pubmed">30564562</ArticleId></ArticleIdList></Reference><Reference><Citation>Kingstone T, Taylor AK, O&#x2019;Donnell CA, Atherton H, Blane DN, Chew-Graham CA. Finding the &#x2018;right&#x2019; GP: a qualitative study of the experiences of people with long-COVID. BJGP Open 2020; 4(5).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7880173</ArticleId><ArticleId IdType="pubmed">33051223</ArticleId></ArticleIdList></Reference><Reference><Citation>Maury A, Lyoubi A, Peiffer-Smadja N, de Broucker T, Meppiel E. Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians. Rev Neurol (Paris) 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7832485</ArticleId><ArticleId IdType="pubmed">33446327</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldini T, Asioli GM, Romoli M, et al. Cerebral venous thrombosis and SARS-CoV-2 infection: a systematic review and meta-analysis. Eur J Neurol 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8014715</ArticleId><ArticleId IdType="pubmed">33426733</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers JP, Chesney E, Oliver D, et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry 2020; 7(7): 611&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7234781</ArticleId><ArticleId IdType="pubmed">32437679</ArticleId></ArticleIdList></Reference><Reference><Citation>Bacaro V, Chiabudini M, Buonanno C, et al. Insomnia in the Italian Population During Covid-19 Outbreak: A Snapshot on One Major Risk Factor for Depression and Anxiety. Front Psychiatry 2020; 11: 579107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7769843</ArticleId><ArticleId IdType="pubmed">33384625</ArticleId></ArticleIdList></Reference><Reference><Citation>Mieczkowska K, Deutsch A, Borok J, et al. Telogen effluvium: a sequela of COVID-19. Int J Dermatol 2021; 60(1): 122&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7753411</ArticleId><ArticleId IdType="pubmed">33226117</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao YM, Shang YM, Song WB, et al. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine 2020; 25: 100463.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7361108</ArticleId><ArticleId IdType="pubmed">32838236</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng CK, Chan JW, Kwan TL, et al. Six month radiological and physiological outcomes in severe acute respiratory syndrome (SARS) survivors. Thorax 2004; 59(10): 889&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1746851</ArticleId><ArticleId IdType="pubmed">15454656</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q, Zhang Z, Shi Y, Jiang Y. Emerging H7N9 influenza A (novel reassortant avian-origin) pneumonia: radiologic findings. Radiology 2013; 268(3): 882&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">23821754</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y, Tan C, Wu J, et al. Impact of coronavirus disease 2019 on pulmonary function in early convalescence phase. Respir Res 2020; 21(1): 163.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7323373</ArticleId><ArticleId IdType="pubmed">32600344</ArticleId></ArticleIdList></Reference><Reference><Citation>Hui DS, Joynt GM, Wong KT, et al. Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors. Thorax 2005; 60(5): 401&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1758905</ArticleId><ArticleId IdType="pubmed">15860716</ArticleId></ArticleIdList></Reference><Reference><Citation>Rouse BT, Sehrawat S. Immunity and immunopathology to viruses: what decides the outcome? Nat Rev Immunol 2010; 10(7): 514&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3899649</ArticleId><ArticleId IdType="pubmed">20577268</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore JB, June CH. Cytokine release syndrome in severe COVID-19. Science 2020; 368(6490): 473&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">32303591</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngai JC, Ko FW, Ng SS, To KW, Tong M, Hui DS. The long-term impact of severe acute respiratory syndrome on pulmonary function, exercise capacity and health status. Respirology 2010; 15(3): 543&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7192220</ArticleId><ArticleId IdType="pubmed">20337995</ArticleId></ArticleIdList></Reference><Reference><Citation>Suliman YA, Dobrota R, Huscher D, et al. Brief Report: Pulmonary Function Tests: High Rate of False-Negative Results in the Early Detection and Screening of Scleroderma-Related Interstitial Lung Disease. Arthritis Rheumatol 2015; 67(12): 3256&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">26316389</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason L, Benton M, Torres-Harding S, Muldowney K. The impact of energy modulation on physical functioning and fatigue severity among patients with ME/CFS. Patient Educ Couns 2009; 77(2): 237&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2767446</ArticleId><ArticleId IdType="pubmed">19356884</ArticleId></ArticleIdList></Reference><Reference><Citation>White PD, Goldsmith KA, Johnson AL, et al. Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial. Lancet 2011; 377(9768): 823&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3065633</ArticleId><ArticleId IdType="pubmed">21334061</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrews PJ, Pendolino AL, Ottaviano G, et al. Olfactory and taste dysfunction among mild-to-moderate symptomatic COVID-19 positive health care workers: An international survey. Laryngoscope Investig Otolaryngol 2020; 5(6): 1019&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7752034</ArticleId><ArticleId IdType="pubmed">33365393</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho-Schneider C, Laurent E, Lemaignen A, et al. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7534895</ArticleId><ArticleId IdType="pubmed">33031948</ArticleId></ArticleIdList></Reference><Reference><Citation>Chopra V, Flanders SA, O&#x2019;Malley M, Malani AN, Prescott HC. Sixty-Day Outcomes Among Patients Hospitalized With COVID-19. Ann Intern Med 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7707210</ArticleId><ArticleId IdType="pubmed">33175566</ArticleId></ArticleIdList></Reference><Reference><Citation>Galvan-Tejada CE, Herrera-Garcia CF, Godina-Gonzalez S, et al. Persistence of COVID-19 Symptoms after Recovery in Mexican Population. Int J Environ Res Public Health 2020; 17(24).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7765113</ArticleId><ArticleId IdType="pubmed">33327641</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrigues E, Janvier P, Kherabi Y, et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect 2020; 81(6): e4&#x2013;e6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7445491</ArticleId><ArticleId IdType="pubmed">32853602</ArticleId></ArticleIdList></Reference><Reference><Citation>Horvath L, Lim JWJ, Taylor JW, et al. Smell and taste loss in COVID-19 patients: assessment outcomes in a Victorian population. Acta Otolaryngol 2020: 1&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">33307905</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamal M, Abo Omirah M, Hussein A, Saeed H. Assessment and characterisation of post-COVID-19 manifestations. Int J Clin Pract 2020: e13746.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7536922</ArticleId><ArticleId IdType="pubmed">32991035</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S, Barnett J, Brill SE, et al. &#x2018;Long-COVID&#x2019;: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Munro KJ, Uus K, Almufarrij I, Chaudhuri N, Yioe V. Persistent self-reported changes in hearing and tinnitus in post-hospitalisation COVID-19 cases. Int J Audiol 2020; 59(12): 889&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">32735466</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonnweber T, Boehm A, Sahanic S, et al. Persisting alterations of iron homeostasis in COVID-19 are associated with non-resolving lung pathologies and poor patients&#x2019; performance: a prospective observational cohort study. Respir Res 2020; 21(1): 276.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7575703</ArticleId><ArticleId IdType="pubmed">33087116</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Luciano S, Geddes JR, Harrison PJ. Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA. Lancet Psychiatry 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7820108</ArticleId><ArticleId IdType="pubmed">33181098</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>